Advanced search
Publication Cover
Leukemia & Lymphoma Volume 24, 1997 - Issue 5-6
Submit an article Journal homepage
28
Views
13
CrossRef citations to date
0
Altmetric
Original Article

A Phase-II Study with Idarubicin, Ifosfamide and VP-16 (IIVP-16) in Patients with Refractory or Relapsed Aggressive and High Grade non-Hodgkin's Lymphoma

A. Engert Klinik I fñ Innere Medizin, Universität zu KÖln, KÖln, Joseph-Stelzmann-Strab˜e 9, D-50924, KÖln, GÖttingen, Germany
,
R. Schnell Klinik I fñ Innere Medizin, Universität zu KÖln, KÖln, Joseph-Stelzmann-Strab˜e 9, D-50924, KÖln, GÖttingen, Germany
,
F. Kñpper Klinik I fñ Innere Medizin, Universität zu KÖln, KÖln, Joseph-Stelzmann-Strab˜e 9, D-50924, KÖln, GÖttingen, Germany
,
M. Reiser Klinik I fñ Innere Medizin, Universität zu KÖln, KÖln, Joseph-Stelzmann-Strab˜e 9, D-50924, KÖln, GÖttingen, Germany
,
M. Engelhard Medizinische Klinik, Universitätsklinikum Essen, Essen, GÖttingen, Germany
,
M. Wilhelm Universitätsklinik Wñrzburg, Medizinische Poliklinik, Wñrzburg, GÖttingen, Germany
,
B. Lathan Klinik I fñ Innere Medizin, Universität zu KÖln, KÖln, Joseph-Stelzmann-Strab˜e 9, D-50924, KÖln, GÖttingen, Germany
,
S. Baltes-Engler Pharmacia/Farmitalia, Freiburg, GÖttingen, Germany
,
B. Winterhalter Pharmacia/Farmitalia, Freiburg, GÖttingen, Germany
,
M. E. Scheulen Innere Klinik, Tumorforschung, Universitätsklinikum Essen, Essen, GÖttingen, Germany
,
B. Dederichs Klinik und Poliklinik fñr Nuklearmedizin, Universitat zu KÖln, KÖln, GÖttingen, Germany
,
H. Tesch Klinik I fñ Innere Medizin, Universität zu KÖln, KÖln, Joseph-Stelzmann-Strab˜e 9, D-50924, KÖln, GÖttingen, Germany
,
B. Wörmann Med. Universitätsklinik GÖttingen, Zentrum fñr Innere Medizin, GÖttingen, Germany
&
V. Diehl Klinik I fñ Innere Medizin, Universität zu KÖln, KÖln, Joseph-Stelzmann-Strab˜e 9, D-50924, KÖln, GÖttingen, Germany
 show all
Pages 513-522 | Received 20 May 1996, Published online: 01 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

G. H. Jackson, B. Angus, P. J. Carey, R. D. Finney, M. J. Galloway, D. K. Goff, A. Haynes, A. L. Lennard, R. C. F. Leonard, I. G. Mcquaker, S. J. Proctor, N. Russell, K. Windebank & P. R. A. Taylor. (2000) High Dose Ifosfamide in Combination with Etoposide and Epirubicin Followed by Autologous Stem Cell Transplantation in the Treatment of Relapsecd/Refractory Hodgkin's Disease: a Report on Toxicity and Efficacy On behalf of the Scotland and Newcastle Lymphoma Group. Leukemia & Lymphoma 37:5-6, pages 561-570.
Read now
M. Reiser, A. Josting, P. Dias Wickramanayake, A. Draube, C. Scheid, H. Tesch, J. Wolf, V. Diehl & A. Engert. (1999) Dexa-BEAM is not Effective in Patients with Relapsed or Resistant Aggressive High-Grade Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 33:3-4, pages 305-312.
Read now
M. Reiser, R. Schnell, G. Straub, P. Borchmann, M. Wilhelm, R. Übelacker, B. Wörmann, R. Münch, V. Diehl & A. Engert. (1998) DIZE (Dexamethasone, Idarubicin, and Continuous Infusion of Ifosfamide and Etoposide): an Effective and Well-Tolerated New Regimen for Patients with Relapsed Lymphoma. Leukemia & Lymphoma 31:3-4, pages 359-366.
Read now

Articles from other publishers (10)

Jiexian Ma, Shunrong Sun, Yingwei Hu, Min Wu, Lin Shen, Wulipan Fulati, Zilan Huang, Wensi Qian, Pingping Chen, Mingyue Chen & Yanhui Xie. (2022) Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL. Bone Marrow Transplantation 57:10, pages 1612-1614.
Crossref
Chen Tian, Yueyang Li, Su Liu, Zehui Chen, Yizhuo Zhang, Yong Yu, Hongliang Yang, Haifeng Zhao, Zhigang Zhao, Tian Yuan & Yafei Wang. (2021) Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients. Scientific Reports 11:1.
Crossref
P. Meusers, M. Dreyling, G. Brittinger & M. Engelhard. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie 2953 2986 .
Basak Oyan, Yener Koc, Evren Ozdemir, Ayse Kars, Alev Turker, Gulten Tekuzman & Emin Kansu. (2005) Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 11:9, pages 688-697.
Crossref
A. Josting, M. Sieniawski, J.-P. Glossmann, O. Staak, L. Nogova, N. Peters, M. Mapara, B. Dörken, Y. Ko, B. Metzner, J. Kisro, V. Diehl & A. Engert. (2005) High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study. Annals of Oncology 16:8, pages 1359-1365.
Crossref
Huseyin Abali, Basak Oyan, Yener Koc, Ayse Kars, Ibrahim Barista, Aysegul Uner, Alev Turker, Figen Demirkazik, Fatma Tekin, Gulten Tekuzman & Emin Kansu. (2005) IIVP Salvage Regimen Induces High Response Rates in Patients With Relapsed Lymphoma Before Autologous Stem Cell Transplantation. American Journal of Clinical Oncology 28:3, pages 264-269.
Crossref
P.L. Zinzani. (2003) Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin’s lymphoma and Hodgkin’s disease: the Italian experience. Annals of Oncology 14, pages i43-i45.
Crossref
Yener Koc & David P. Schenkein. 1999. Diagnostic and Therapeutic Advances in Hematologic Malignancies. Diagnostic and Therapeutic Advances in Hematologic Malignancies 47 73 .
P. Borchmann, R. Schnell, V. Diehl & A. Engert. (1998) New drugs in the treatment of Hodgkin’s disease. Annals of Oncology 9, pages s103-s108.
Crossref
M. Engelhard, G. Trenn & G. Brittinger. 1998. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 333 372 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.